P01.095 The use of TTFields for newly diagnosed GBM patients in Germany in routine clinical care (TIGER: TTFields in Germany in routine clinical care)

BACKGROUND: Glioblastoma (GBM) is the most common malignant primary brain tumor. Survival in GBM has remained essentially unchanged since 2005 despite numerous clinical Phase 3 trials conducted. Tumor treating fields (TTFields) are low-intensity, intermediate frequency, alternating electric fields t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Bähr, O, Tabatabai, G, Fietkau, R, Goldbrunner, R, Glas, M
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2018
Matèries:
Poster Presentations
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6144436/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy139.137
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars